3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1 Uses, Dosage, Side Effects and more

3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1 is under investigation in clinical trial NCT03218917 (Assessment of INS1007 in Subjects With Non-cystic Fibrosis Bronchiectasis).

Attribute	Details
Trade Name	3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1
Generic	Brensocatib
Brensocatib Other Names	(S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide, Brensocatib
Type
Formula	C23H24N4O4
Weight	Average: 420.469 Monoisotopic: 420.179755269
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph